MentionFox
Home › funding signals › Akari Therapeutics Plc
Company · SEC filings

Akari Therapeutics Plc funding history

Akari Therapeutics Plc has 4 Form D filings on record, from 2023-10-19 to 2026-06-03. Together its new offerings report $8.08M sold.

Funding historyFounders and team

What do you want to do with Akari Therapeutics Plc?

Based
TAMPA, FLORIDA
Industry group
Other Health Care
Filings
4
Raised (new offerings)
$8.08M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-06-03New offering
first sale 2026-05-20
$1.83M$5.50MSEC filing
2025-10-24New offering
first sale 2025-10-16
$6.25M$6.25MSEC filing
2024-01-09Filing——SEC filing
2023-10-19Filing——SEC filing

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Akari Therapeutics Plc's own filings with the SEC. The people those filings name are on the team page.

Cite this page

Permanent URL: https://mentionfox.com/company/akari-therapeutics-plc
Last updated 2026-09-26
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Akari Therapeutics Plc funding history: 4 SEC filings, $8.08M raised. MentionFox, 2026-09-26. https://mentionfox.com/company/akari-therapeutics-plc